Management of cytomegalovirus-related rhegmatogenous retinal detachments

Ophthalmic Surgery and Lasers

Volumn 29, Issue 11, 1998, Pages 916-925

  Baumal, Caroline R ^a   Reichel, Elias ^b  

^a WILLS EYE HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS INFECTION; HUMAN; KIRISAWA UVEITIS; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; RETINA DETACHMENT; REVIEW; RISK ASSESSMENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; VISUAL IMPAIRMENT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; RECURRENCE; RETINAL DETACHMENT; RISK FACTORS; SCLERAL BUCKLING; SILICONE OILS; VISUAL ACUITY; VITRECTOMY;

EID: 0031755566     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Baumal CR, Levin AV, Kavalec C, Petric M, Khan H, Read S. Screening for cytomegalovirus retinitis in children. Arch Pediatr Adolesc Med. 1996;150:1186-1192.
2. Friedman AH. The retinal lesions of the acquired immune deficiency syndrome. Trans Am Ophthalmol Soc. 1984;82:447-491.
3. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989;96:1092-1099.
4. Holland GN, Sison RF, Jatulis DE, et al. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. Ophthalmology. 1990;97:204-211.
5. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with proteaseinhibitor treatment in patients with AIDS. Am J Ophthalmol. 1997;124:199-205.
6. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997;124:227-233.
7. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
8. Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995;333:670.
9. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 1996;114:821-827.
10. Holland GN, Sakamoto MJ, Hardy D, et al. Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome: use of an experimental drug 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Arch Ophthalmol. 1986;104: 1794-1800.
11. Holland GN, Sidikaro Y, Kreiger AE, et al. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987;94:815-823.
12. Henderly DE. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology. 1987;94: 425-434.
13. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:75-80.
14. Orellana J, Teich SA, Friedman AH, Lerebours F, Winterkorn J, Mildvan D. Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis. Ophthalmology. 1987;94:831-838.
15. Gross JG, Bozzette SA, Mathews WC, et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990;97:681-686.
16. Studies of Ocular Complications of AIDS Research Group in Collaboration With the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus trial. 4. Visual outcomes. Ophthalmology. 1994;101: 1250-1261.
17. Lalezari J, Stagg R, Kuppermann B, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial. Ann Intern Med. 1997;126:257-263.
18. Studies of the Ocular Complications of AIDS Research Group in Collaboration With the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial: a randomized, controlled trial. Ann Intern Med. 1997;126:264-274.
19. Cantrill HL, Henry K, Melroe H, Knoblich WH, Ramsay RC, Balfour HH Jr. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Ophthalmology. 1989;96:367-374.
20. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Arch Ophthalmol. 1994;112:1531-1539.
21. Duker JS, Robinson M, Anand R, Ashton P. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS. Ophthalmic Surg Lasers. 1995;26:442-448.
22. Broughton WL, Cupples HP, Parver LM. Bilateral retinal detachment following cytomegalovirus retinitis. Arch Ophthalmol. 1978;96:618-619.
23. Meredith TA, Aaberg TA, Reeser FH. Rhegmatogenous retinal detachment complicating cytomegalovirus retinitis. Am J Ophthalmol. 1979;87:793-796.
24. Freeman WR, Henderly DE, Wan WL, et al. Prevalence, pathophysiology and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1987; 103:527-536.
25. Jabs DA, Enger C, Haller J, deBustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991;109:794-799.
26. Orellana J, Teich SA, Lieberman RM, Restrepo S, Peairs R. Treatment of retinal detachments in patients with the acquired immune deficiency syndrome. Ophthalmology. 1991;98:939-943.
27. Sidikaro Y, Silver L, Holland GN, Kreiger AK. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology. 1991;98:129-135.
28. Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Flores-Aguilar M. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992;99:466-474.
29. Roarty JD, Fisher EJ, Nussbaum JJ. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1993;100:1685-1688.
30. Kuppermann BD, Flores-Aguilar M, Quiceno JI, et al. A masked progressive evaluation of outcome parameters for cytomegalovirus-related retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology. 1994;101:46-55.
31. McCluskey P, Grigg J, Playfair TJ. Retinal detachments in patients with AIDS and CMV retinopathy: a role for laser photocoagulation. Br J Ophthalmol. 1995;79: 153-156.
32. Studies of the Ocular Complications of AIDS Research Group in Collaboration With the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the foscarnet-ganciclovir cytomegalovirus retinitis trial. Am J Ophthalmol. 1997;124:61-70.
33. Gangan PA, Besen G, Munguia D, Freeman WR. Macular serous exudation in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. Am J Ophthalmol. 1994;118:212-219.
34. Davis JL, Serfass MS, Lai MY, Trask DK, Azen SP. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol 1995;113:1401-1409.
35. Regillo CD, Vander JF, Duker JS, Fischer DH, Belmont JB, Kleiner R. Repair of retinitis-related retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:21-27.
36. Irvine AR. Treatment of retinal detachment due to cytomegalovirus retinitis in patients with AIDS. Trans Am Ophthalmol Soc. 1991;89:349-367.
37. Freeman WR, Friedberg DN, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116:713-720.
38. Studies of the Ocular Complications of AIDS Research Group in Collaboration With the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
39. Lim JI, Enger C, Haller JA, et al. Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology. 1994;101: 264-269.
40. Chuang EL, Davis JL. Management of retinal detachment associated with CMV retinitis in AIDS patients. Eye. 1992;6:28-34.
41. Vrabec TR. Laser photocoagulation repair of maculasparing cytomegalovirus-related retinal detachment. Ophthalmology. 1997;104:2062-2067.
42. Davis JL, Hummer J, Feuer WJ. Laser photocoagulation for retinal detachments and retinal tears in cytomegalovirus retinitis. Ophthalmology. 1997;104: 2053-2061.
43. Teich SA, Orellana J, Friedman AH. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1987;104:312-313.
44. Margolis TI, Duker JS, Reichel E, Rutledge BK, Morley MG, Davis JL. Repair of retinal detachments related to cytomegalovirus retinitis in eyes with ganciclovir implants. Invest Ophthalmol Vis Sci. 1995; 36:S778. Abstract.
45. Nasemann JE, Mutsch A, Wiltfang R, Klauss V. Early pars plana vitrectomy without buckling procedure in cytomegalovirus retinitis-induced retinal detachment. Retina. 1995;15:111-116.
46. Garcia RF, Flores-Aguilar M, Quiceno JI, et al. Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology. 1995;102:236-245.
47. Stefansson E, Anderson MM Jr, Landers MB, Tiedeman JS, McCuen BW. Refractive changes from use of silicone oil in vitreous surgery. Retina. 1988; 8:20-23.
48. Meldrum ML, Aaberg TM, Patel A, Davis J. Cataract extraction after silicone oil repair of retinal detachments due to necrotizing retinitis. Arch Ophthalmol. 1996;114:885-892.
49. Dugel PU, Liggett PE, Lee MB, et al. Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991;112:235-242.
50. Culbertson WW, Blumenkranz MS, Haines H, Gass DM, Mitchell KB, Norton EW. The acute retinal necrosis syndrome: Part 2. Hisropathology and etiology. Ophthalmology. 1982;89:1317-1325.
51. Culbertson WW, Blumenkranz MS, Pepose JS, Stewart JA, Curtin VT. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology. 1986;93:559-569.
52. Lewis ML, Culbertson WW, Post JD, Miller D, Kokame GT, Dix RD. Herpes simplex virus type 1: a cause of the acute retinal necrosis syndrome. Ophthalmology. 1989;96:875-878.
53. Duker JS, Nielsen JC, Eagle RC Jr, Bosley TM, Granadier R, Benson WE. Rapidly progressive acute retinal necrosis secondary to herpes simplex virus, type 1. Ophthalmology. 1990;97:1638-1643.
54. Cunningham ET Jr, Short GA, Irvine AR, Duker JS, Margolis TP. Acquired immunodeficiency syndrome-associated herpes simplex virus retinitis: clinical description and use of a polymerase chain reaction-based assay as a diagnostic tool. Arch Ophthalmol. 1996;114:834-840.
55. Culbertson WW, Clarkson JG, Blumenkranz M, Lewis ML. Acute retinal necrosis. Am J Ophthalmol. 1983; 96:683-685.
56. Clarkson JG, Blumenkranz MS, Culbertson WW, Flynn HW Jr, Lewis ML. Retinal detachment following the acute retinal necrosis syndrome. Ophthalmology. 1984;91:1665-1668.
57. Fisher JP, Lewis ML, Blumenkranz M, et al. The acute retinal necrosis syndrome: Parr 1. Clinical manifestations. Ophthalmology. 1982;89:1309-1316.
58. Matsuo T, Morimoto K, Matsuo N. Factors associated with poor visual outcome in acute retinal necrosis. Br J Ophthalmol. 1991;75:450-454.
59. Blumenkranz MS, Culbertson WW, Clarkson JG, Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986;93: 296-300.
60. Sternberg P Jr, Han DP, Yeo JH, et al. Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology. 1988;95:1389-1393.